uBriGene Biosciences
PrivateLast Round
VC Round
Dec 24, 2024
Total Funding Raised
$66M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
uBriGene Biosciences is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
uBriGene Biosciences Comparables
Compare uBriGene Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Innoforce Pharmaceuticals | 90% | |
| CoJourney | 85% | |
| Beijing Fiveplus Gene Technology | 84% | |
uBriGene Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 24, 2024 | ||||
| Series C Extension | Apr 19, 2023 | ||||
| Series C | Sep 27, 2022 | ||||
| Series B | Sep 16, 2021 | ||||
| Series A | Dec 16, 2020 | ||||
Angel | Oct 1, 2019 |
uBriGene Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGI Co-Win | Series C |
| IDG Capital | Series C, Series B |
| 中信金石投资有限公司 | Series C |
| Innovator Capital | Series C |
| Wenzhou State-owned Financial Capital Management | Series C |
| Beijing Fangfu Venture Capital Management | Series C Extension, Series C, Series A, Series B |
| Huagai Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 11, representing 48% of headcount.
- Jul 13, 2026
Open roles increased from 0 to 5, representing 22% of headcount.
uBriGene Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about uBriGene Biosciences's valuation, stock price, and market status.